Given the enhanced recruitment of ERα to intergenic regions of the prostate genome, we evaluated the likelihood that ERα might influence transcriptional output and thereby the repertoire of non-coding RNA in the context of prostate cancer. Here, ESR1 is linked to prostate carcinoma.